Total medical devices industry cross border deals worth $4.91bn were announced globally for December 2020, with the $2.8bn acquisition of BioTelemetry being the sector’s biggest investment, according to GlobalData’s deals database.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

The value marked an increase of 918.2% over the previous month of $482.22m and a rise of 108.05% when compared with the last 12-month average of $2.36bn.

In terms of number of cross border deals, the sector saw a drop of 7.89% with 35 deals in December 2020 when compared to the last 12-month average of 38 deals.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

In value terms, North America led the activity with cross border deals worth $4.79bn in December 2020.

See Also:

Medical Devices industry cross border deals in December 2020: Top deals

The top five cross border deals accounted for 85.8% of the overall value during December 2020.

The combined value of the top five cross border deals stood at $4.21bn, against the overall value of $4.91bn recorded for the month.

The top five medical devices industry cross border deals of December 2020 tracked by GlobalData were:

1) Koninklijke Philips’ $2.8bn acquisition of BioTelemetry

2) The $700m private equity deal with Verily Life Sciences by Alphabet, Ontario Teachers’ Pension Plan, Silver Lake Partners and Temasek Holdings (Private)

3) Richter Gedeon Nyrt’s $263.5m asset transaction with Janssen Pharmaceutica

4) The $250m acquisition deal of EmendoBio by AnGes

5) Baillie Gifford, Franklin Templeton Investments, Google, Novo Holdings and T Rowe Price Associates’ venture financing deal with Tempus Labs for $200m.